BROWSE BY STUDY TYPE OR CONFERENCE
All
- All
- MODEL VALIDATION
- CLINICAL VALIDATION
- AACR
- ASCO
- ASH
BROWSE BY YEAR
All
- All
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- Archive
Predicting GBM response to targeted therapeutics using simulation with ex vivo validations
ASCO Annual Meeting,
Predictive analysis of microenvironment impact on clinical outcomes to drug agents using simulation of myeloproliferative neoplasms
ASCO Annual Meeting,
In silico modeling predicts drug sensitivity of patient-derived cancer cells
Journal of Translational Medicine,
Individualized therapy identified using simulation for bortezomib resistant patient with ex vivo validation
AACR Annual Meeting,
A Predictive Model of an Oral Inflammatory Response
AADR Annual Meeting & Exhibition,
Histatin 5 binds to Porphyromonas gingivalis hemagglutinin B (HagB) and alters HagB-induced chemokine responses
Nature, Scientific Reports,
PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance
British Journal of Haematology,
Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs